$7.12B
$1.61 Million
0.0% of portfolio
88,114
Q2 2025
New
$0
$663,000
0.0% of portfolio
73,228
Q4 2024
Reduced 4.5%
$0
$457,000
0.0% of portfolio
39,131
Q2 2025
Added 0.77%
$0
$388,000
0.0% of portfolio
27,665
Q2 2025
Reduced 11.38%
$0
$391,000
0.0% of portfolio
48,292
Q2 2025
Added 1.55%
$0
$122,000
0.0% of portfolio
10,500
Q2 2025
Reduced 52.02%
$0
$626,000
0.0% of portfolio
55,610
Q2 2025
Added 4.71%
$0
$200,000
0.0% of portfolio
17,026
Q2 2025
Added 1.19%
$0
$1.28 Million
0.0% of portfolio
128,919
Q2 2025
Added 8.46%
$0
$108,000
0.0% of portfolio
10,146
Q1 2025
Reduced 16.47%
$0
$148,000
0.0% of portfolio
12,987
Q2 2025
Reduced 1.89%
$0
$844,000
0.0% of portfolio
75,626
Q2 2025
Added 5.86%
$0
$2.72 Million
0.0% of portfolio
262,557
Q2 2025
Added 401.32%
$0
$287,000
0.0% of portfolio
10,847
Q2 2025
Reduced 1.91%
$0
$136,000
0.0% of portfolio
11,995
Q2 2025
Added 2.31%
$0
$4.2 Million
0.0% of portfolio
302,608
Q2 2025
Added 7.54%
$0
$312,000
0.0% of portfolio
40,211
Q2 2025
Added 3.42%
$0
$665,000
0.0% of portfolio
78,614
Q2 2025
Added 20.35%
$0
$4.8 Million
0.0% of portfolio
598,489
Q2 2025
Reduced 4.97%
$0
$1.84 Million
0.0% of portfolio
340,699
Q2 2025
Added 1.79%
$0
$264,000
0.0% of portfolio
16,701
Q2 2025
Added 3.02%
$0
$794,000
0.0% of portfolio
62,936
Q2 2025
Added 7.29%
$0
$792,000
0.0% of portfolio
38,100
Q2 2025
Reduced 6.52%
$0
$687,000
0.0% of portfolio
47,949
Q2 2025
Reduced 26.02%
$0
$919,000
0.0% of portfolio
91,353
Q2 2025
Reduced 0.22%
$0
$2.14 Million
0.0% of portfolio
190,839
Q2 2025
Added 9.25%
$0
$3.9 Million
0.0% of portfolio
202,113
Q2 2025
Added 8.72%
Nuveen Churchill Direct Lend
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 4.49%
$0
$251,000
0.0% of portfolio
2,679
Q2 2025
New
$0
$2.42 Million
0.0% of portfolio
57,772
Q2 2025
Added 2.69%
$0
$629,000
0.0% of portfolio
17,473
Q2 2025
Added 2.21%
$0
$616,000
0.0% of portfolio
17,361
Q2 2025
Added 7.12%
$0
$268,000
0.0% of portfolio
8,095
Q2 2025
New
Oaktree Specialty Lending CO
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 28.5%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 11.18%
$6.45B
$3.12 Million
0.0% of portfolio
145,992
Q2 2025
Added 5.05%
-
$0
0.0% of portfolio
-
Q2 2025
Added 14.87%
$6.48B
$3.03 Million
0.0% of portfolio
29,975
Q2 2025
Added 13.89%
$5.16B
$7,000
0.0% of portfolio
13,940
Q2 2025
Reduced 7.56%
$10B
$2.47 Million
0.0% of portfolio
84,578
Q2 2025
Added 7.41%
$274M
$31,000
0.0% of portfolio
16,000
Q2 2025
New
$2.33B
$594,000
0.0% of portfolio
31,456
Q2 2025
Reduced 2.36%
$989M
$258,000
0.0% of portfolio
7,999
Q2 2025
Added 0.69%
$69.7M
$5,000
0.0% of portfolio
10,500
Q2 2025
Reduced 3.14%
Os Therapies Incorporated
-
$0
0.0% of portfolio
-
Q1 2025
New
$3.39B
$4.86 Million
0.0% of portfolio
226,687
Q2 2025
Added 27.04%
$0
$92,000
0.0% of portfolio
22,118
Q2 2025
Added 90.38%
$0
$2.18 Million
0.0% of portfolio
61,399
Q2 2025
Added 178.14%
$0
$2.09 Million
0.0% of portfolio
49,969
Q2 2025
Added 11.9%
-
$0
0.0% of portfolio
-
Q2 2025
Added 44.83%